Evidence map›Paper›PMID 41199535›Full record

ReviewMedical science monitor : international medical journal of experimental and clinical research2025

Facial Injectable Fillers in Aesthetic Medicine: Clinical Applications and Safety Strategies.

Jie Liu, Ming Gao, Huilin Hu, Hanyu Pang, Yuyang Liu, Peng Zhang

Abstract readReview
In one paragraph

Review in Medical science monitor : international medical journal of experimental and clinical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jie LiuDermatology Department, Chengfei Hospital, Chengdu, Sichuan, China.
Ming GaoClinical Medicine Department, Chengdu University, Chengdu, Sichuan, China.
Huilin HuClinical Medicine Department, Chengdu University, Chengdu, Sichuan, China.
Hanyu PangClinical Medicine Department, Chengdu University, Chengdu, Sichuan, China.ORCID 0009-0006-7977-9708
Yuyang LiuClinical Medicine Department, Chengdu University, Chengdu, Sichuan, China.
Peng ZhangDermatology Department, Chengfei Hospital, Chengdu, Sichuan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Due to the increasing demand for facial rejuvenation and aesthetic enhancement, the use of facial injectable fillers has rapidly expanded and become one of the most widely used cosmetic procedures. These fillers are primarily used for facial rejuvenation, soft tissue augmentation, wrinkle removal, and correcting volume loss or facial disproportion caused by aging, trauma, or infection. Commonly used materials include hyaluronic acid, polycaprolactone, calcium hydroxylapatite, and poly-L-lactic acid, each offering unique benefits in terms of safety, durability, and biocompatibility. Additionally, the longevity and mechanism of action vary significantly among fillers. Hyaluronic acid provides immediate volume but requires crosslinking for durability, while polycaprolactone and poly-L-lactic acid stimulate collagen production for longer-lasting effects. Minimally invasive procedures with injectable fillers provide advantages such as enhanced privacy, reduced recovery time, and lower risk, compared with traditional surgery. However, potential adverse reactions - ranging from mild swelling and pain to severe complications, such as vascular occlusion, nodules, and even blindness - remain a critical concern. A thorough understanding of facial anatomy, particularly of vascular danger zones, is essential to mitigate risks, such as tissue necrosis and vision loss. In this review, we comprehensively analyze the properties, clinical applications, and mechanisms of action of major filler materials, while emphasizing reported complications and their management strategies. By integrating current evidence, we aim to guide clinicians in selecting appropriate fillers, optimizing injection techniques, and minimizing risks, thereby improving patient outcomes in aesthetic medicine.

Indexed as

Cosmetic TechniquesDermal FillersFaceBiocompatible MaterialsDurapatiteEstheticsHumansHyaluronic AcidPolyestersRejuvenationSkin AgingBiocompatible MaterialsDermal FillersDurapatiteHyaluronic AcidPolyesterspoly(lactide)

Identifiers

PMID41199535
PMCPMC12684002

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.